FDA approves first drug to treat a rare bone marrow disease

The U.S. Food and Drug Administration today approved Jakafi (ruxolitinib), the first drug approved to specifically treat patients with the bone marrow disease myelofibrosis.

Food and Drug Recall.org

FDA approves first drug to treat a rare bone marrow disease

Subscribe

Categories